Current stage-Inflammatory breast cancer - Page 2 of 3 Posts on Medivizor
Navigation Menu

Current stage-Inflammatory breast cancer Posts on Medivizor

Does pregnancy affect survival?

Does pregnancy affect survival?

Posted by on Nov 16, 2013 in Breast cancer | 0 comments

Does pregnancy affect survival? This study evaluated the effect of pregnancy on the survival of women with BRCA associated breast cancer. Hereditary breast cancer (associated with a mutation in either the BRCA1 or BRCA2 gene) typically presents itself in younger women. Consequently, the onset of breast cancer often overlaps with pregnancy....

Read More

Could menopausal symptoms predict prognosis?

Could menopausal symptoms predict prognosis?

Posted by on Oct 27, 2013 in Breast cancer | 0 comments

In a nutshell This present study evaluated the role of menopausal symptoms in the prognosis of breast cancer patients. Some background Menopause is the period in a woman’s life after menstruation stops and the ovaries become inactive, defined as 12 months after a woman's last period. With menopause, the level of female sex hormones such...

Read More

A new treatment option for breast cancer

A new treatment option for breast cancer

Posted by on Sep 23, 2013 in Breast cancer | 1 comment

In a nutshell This phase II clinical trial examined the safety and efficacy of adding a drug called rh-endostatin (Endostar) to chemotherapy in breast cancer patients. Some background Cancer cells need blood supply in order to grow. As cancer grows, it forms its own blood vessels, a process called angiogenesis. Therefore, anti-angiogenesis...

Read More

Evaluating quality of life in overweight and obese patients with breast cancer who undergo radiotherapy

Evaluating quality of life in overweight and obese patients with breast cancer who undergo radiotherapy

Posted by on Aug 31, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated whether the Body Mass Index (BMI) influences the quality of life of breast cancer patients treated with radiotherapy.  Some background The Body Mass Index (BMI) is a weight to height ratio calculated by dividing a person’s weight in kilograms to their square of height in meters. A normal BMI ranges...

Read More

Tamoxifen reduces the risk of contralateral breast cancer in women with BRCA1 or BRCA2

Posted by on Aug 25, 2013 in Breast cancer | 0 comments

In a nutshell This study examined whether tamoxifen (nolvadex) can reduce the risk of contralateral breast cancer in women diagnosed with breast cancer and the BRCA1 or BRCA2 genetic mutation. Some background The BRCA1 and BRCA2 genetic mutations are associated with a high risk of developing breast cancer. While prophylactic mastectomies (a...

Read More

Reducing side effects of ixabepilone by reducing dosage

Posted by on Aug 19, 2013 in Breast cancer | 0 comments

In a nutshell In this study researchers reviewed the adverse effects of the chemotherapy drug ixabepilone for patients with metastatic breast cancer and how these can be managed by reducing the dosage. Some background Ixabepilone (Ixempra) is a chemotherapy drug approved by the U.S. FDA as treatment for metastatic breast cancer (breast cancer that...

Read More

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Posted by on Jul 27, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined the effect of epoetin alfa (Epogen; Procrit) on anemia (low count of red blood cells) caused by chemotherapy in breast cancer patients. Some background Breast cancer is caused by a defect that makes some breast cancer cells grow and multiply rapidly. One of the treatment options for patients with...

Read More

Phase II clinical trial testing the safety and efficacy of adding entinostat to exemestane therapy in hormone-resistant breast cancer patients

Phase II clinical trial testing the safety and efficacy of adding entinostat to exemestane therapy in hormone-resistant breast cancer patients

Posted by on Jun 5, 2013 in Breast cancer | 0 comments

In a nutshell This phase II clinical trial tested whether a new drug, entinostat, can work in concert with exemestane (a hormone therapy drug), to fight breast cancer that no longer responds to hormone therapy alone. Some background Some breast cancers need estrogen (a female sex hormone) to grow. These breast cancer cells respond to estrogen via...

Read More